SIRT2-deficient murine T cells and SIRT2 blockaded human tumor-infiltrating lymphocytes showed increased glycolysis and oxidative phosphorylation, enhanced proliferation and effector functions and thereby superior antitumor activity (186). The gene discussed is SIRT2; the disease is neoplasm.